Shelter Pharma Ltd

As of 13-Nov, Shelter Pharma Ltd's stock price is declining at 41.25, down 1.93% and underperforming with a total drop of 7.72% over the last three days. The stock is trading below all major moving averages and has significantly lagged behind the benchmark Sensex, which has gained over the same period.

Shelter Pharma has shown consistent growth in net sales and profitability, with net sales increasing from INR 30.06 crore in March 2022 to INR 50.66 crore in March 2025, and profit after tax rising from INR 1.84 crore to INR 7.24 crore during the same period. The company's financial performance reflects a strong upward trend across key metrics.

As of 10-Nov, Shelter Pharma Ltd's stock price is rising to Rs 44.10, up 5.35%, and has outperformed its sector recently. However, it has a year-to-date decline of 20.95%, indicating ongoing long-term challenges despite short-term gains.

As of 17-Oct, Shelter Pharma Ltd's stock price is Rs 41.30, down 6.12% and underperforming its sector. The stock has declined significantly over the past week, month, and year-to-date, contrasting sharply with the overall market's gains.

As of 16-Oct, Shelter Pharma Ltd's stock price is Rs 43.99, up 4.76% today, but it has declined 21.15% year-to-date and underperformed the Sensex. Despite a recent increase in investor interest, the overall trend remains negative compared to broader market performance.

As of 13-Oct, Shelter Pharma Ltd's stock price is Rs 41.60, down 6.41% and underperforming with a total decline of 7.2% over the last two days. The stock is trading below all major moving averages, indicating a bearish trend, and has seen decreased investor participation.

As of 24-Sep, Shelter Pharma Ltd's stock price is at 44.85, having increased by 1.93% recently, but it has declined 4.78% over the past month. Despite a short-term gain, the stock has underperformed year-to-date with a 19.61% decline, contrasting with the broader market's positive trends.

As of 17-Sep, Shelter Pharma Ltd's stock price is at 44.20, down 0.45% and has declined 3.91% over the last five days, underperforming its sector and the benchmark. The stock shows a bearish trend with decreased investor participation and a significant drop in delivery volume.

As of 16-Sep, Shelter Pharma Ltd's stock price is at 44.40, down 1.33% and has underperformed for four consecutive days, with a total decline of 3.48%. The stock has a year-to-date drop of 20.42% and has significantly lagged behind the broader market, which has seen positive returns.

As of 15-Sep, Shelter Pharma Ltd's stock price is at 45.00, down 0.44% and has declined 2.17% over the last three days. The stock has underperformed compared to the Sensex, with a year-to-date decline of 19.34%.

As of 12-Sep, Shelter Pharma Ltd's stock price is at 45.20, down 1.72% and significantly underperforming its sector. Year-to-date, the stock has declined by 18.98%, with a notable drop in investor participation and a contrasting performance compared to the broader market.

As of 11-Sep, Shelter Pharma Ltd's stock price is at 45.99, showing a slight decline today but positive short-term performance. Despite recent gains, it has underperformed year-to-date compared to the broader market, indicating challenges in maintaining momentum.

As of 09-Sep, Shelter Pharma Ltd's stock price is at 46.00, down 0.65%, and has underperformed its sector by 1.28%. Despite recent positive returns over the past week and month, the stock has a year-to-date decline of 17.55%, indicating struggles compared to the broader market, which has seen gains.

As of 08-Sep, Shelter Pharma Ltd's stock price is at 46.30, unchanged, with short-term returns of +2.89% over one week and +6.81% over one month, outperforming the Sensex. However, its year-to-date return is -17.01%, indicating long-term performance concerns despite recent positive trading activity.

As of 05-Sep, Shelter Pharma Ltd's stock price is Rs 46.30, up 4.02% today, reversing a two-day decline and outperforming its sector. Despite recent gains, the stock is down 17.01% year-to-date, indicating mixed performance influenced by increased investor interest.

Shelter Pharma Ltd has declared a 3% dividend, with an ex-date of September 23, 2025. While recent total returns show positive growth in the short to medium term, longer-term returns have been stagnant with no dividends declared in the past few years.

As of 04-Sep, Shelter Pharma Ltd's stock price is at 44.51, down 1.09% recently and 20.22% year-to-date, underperforming against the benchmark index. Despite a recent increase in trading volume, the stock has shown mixed investor sentiment and continues to lag behind broader market trends.

As of 03-Sep, Shelter Pharma Ltd's stock price is 45.00, down 0.22%, and has underperformed its sector by 1.46%. The stock has shown erratic trading patterns, a significant drop in delivery volume, and a year-to-date decline of 19.34%, contrasting sharply with the Sensex's gain of 3.11%.

As of 02-Sep, Shelter Pharma Ltd's stock is priced at 45.10, showing a slight increase but significant volatility due to erratic trading and a 75% drop in delivery volume. Despite a recent 6.37% gain over the month, it has declined 19.16% year-to-date, indicating ongoing challenges in maintaining investor interest.